Long COVID, Regulating AI Medical Advice, and the Hidden Costs of Prior Authorization
Thursday, October 15, 2026
Transcript intelligence
What OpenRounds heard
Source-grounded signals extracted from the episode transcript. Timestamps and supporting excerpts appear when available.
The speaker reports that the FDA is considering evaluating AI systems like physician credentialing but argues for continuous evaluation using simulations instead of episodic exams.
Howie and Harlan discuss new research into the biological mechanisms behind long COVID and other post-infectious syndromes, how the FDA can ensure the safety of AI-powered medical tools, and why prior authorization can discourage necessary care even when treatments are ultimately approved. They also examine an early flu season, the changing calculus of COVID vaccination, and the continuing surge in measles cases.
Daily healthcare AI brief
Get the free healthcare AI briefing
One concise briefing built from reporting, research, policy, blogs, videos, and full podcast transcripts.
Free. Get a sign-in link by email to finish subscribing. An account is created if needed. Unsubscribe anytime. Already subscribed? Sign in to save and personalize.